Watch Ticker

NovoCure Limited Ordinary Shares

Go to NovoCure Limited Ordinary Shares Website

$11.34

-0.42 (-3.57%)
Live
Previous Close

$11.76

Day Range

$11.3 - $11.94

Previous Day Range

$11.13 - $11.77

Market Cap

$1.3 billion USD

Day Vol.

2.9 million

Previous Day Vol.

2.0 million

Currency

USD

Primary Exchange

Nasdaq

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, fo...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Novocure reported 6% revenue growth and 9% patient growth, with plans to seek FDA approval for pancreatic and brain cancer treatments. Despite not being profitable, the company maintains significant cash reserves and potential for future development.

Related tickers: NVCR.

Read Full Article

NovoCure, a leader in oncology treatments using Tumor Treating Fields (TTFields) therapy, reported strong Q1 2025 results with revenue and GAAP earnings surpassing estimates. The company saw robust patient growth and progress in clinical trials, though challenges in gross margins remain.

Related tickers: NVCR.

Read Full Article
Trending Tickers

Please sign in to view